Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.21M Hold
6,283
0.83% 28
2025
Q4
$2.06M Sell
6,283
-15
-0.2% -$4.76K 0.81% 27
2025
Q3
$1.78M Hold
6,298
0.78% 27
2025
Q2
$1.76M Hold
6,298
0.85% 26
2025
Q1
$1.96M Sell
6,298
-169
-3% -$49.9K 1.04% 19
2024
Q4
$1.69M Buy
6,467
+26
+0.4% +$7.71K 0.89% 21
2024
Q3
$2.08M Buy
6,441
+31
+0.5% +$10.1K 1.1% 15
2024
Q2
$2M Buy
6,410
+1
+0% +$294 1.14% 15
2024
Q1
$1.82M Buy
6,409
+2
+0% +$585 1.1% 16
2023
Q4
$1.85M Sell
6,407
-59
-0.9% -$16.1K 1.24% 14
2023
Q3
$1.74M Buy
6,466
+2
+0% +$499 1.25% 15
2023
Q2
$1.56M Hold
6,464
1.13% 16
2023
Q1
$1.56M Sell
6,464
-89
-1% -$21.8K 1.13% 16
2022
Q4
$1.72M Buy
6,553
+1
+0% +$268 1.3% 14
2022
Q3
$1.48M Buy
6,552
+2
+0% +$485 1.17% 15
2022
Q2
$1.59M Sell
6,550
-23
-0.3% -$5.64K 1.16% 16
2022
Q1
$1.59M Sell
6,573
-99
-1% -$22.7K 0.99% 18
2021
Q4
$1.5M Buy
6,672
+1
+0% +$211 0.9% 23
2021
Q3
$1.42M Buy
6,671
+2
+0% +$460 0.93% 18
2021
Q2
$1.63M Sell
6,669
-39
-0.6% -$9.59K 1.12% 15
2021
Q1
$1.67M Buy
6,708
+321
+5% +$76.6K 1.25% 12
2020
Q4
$1.47M Sell
6,387
-122
-2% -$28.1K 1.22% 15
2020
Q3
$1.65M Sell
6,509
-44
-0.7% -$10.9K 1.57% 11
2020
Q2
$1.55M Sell
6,553
-149
-2% -$34K 1.63% 12
2020
Q1
$1.36M Sell
6,702
-319
-5% -$69.7K 1.65% 12
2019
Q4
$1.69M Buy
+7,021
New +$1.55M 1.61% 10

Other funds holding AMGN

S.A. Mason's AMGN Position: Q1 2026 in Review

S.A. Mason held its Amgen (AMGN) position steady in Q1 2026 at 6,283 shares worth $2.21M. The position accounts for 0.83% of the portfolio, ranked #28.

S.A. Mason first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • S.A. Mason held 6,283 shares of Amgen worth $2.21M as of Q1 2026.
  • S.A. Mason left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.83% of S.A. Mason's portfolio in Q1 2026, its #28 holding.
  • S.A. Mason first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on S.A. Mason's 13F filing for Q1 2026, filed 27 Apr 2026.